Comprehensive Mutation Detection of BRCA1/2 Genes Reveals Large Genomic Rearrangements Contribute to Hereditary Breast and Ovarian Cancer in Chinese Women

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5765-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Large BRCA1 and BRCA2 Genomic Rearrangements in Danish High Risk Breast-Ovarian Cancer Families

Breast Cancer Research and Treatment
Cancer ResearchOncology
2008English

Sensitivity of BRCA1/2 Mutation Testing in 466 Breast/Ovarian Cancer Families

Journal of Medical Genetics
Genetics
2003English

Novel Germline Mutations and Unclassified Variants of BRCA1 and BRCA2 Genes in Chinese Women With Familial Breast/Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

BRCA1/2 and Clinical Outcome in a Monoinstitutional Cohort of Women With Hereditary Breast Cancer

Oncology Reports
MedicineCancer ResearchOncology
2013English

Founder BRCA1/2 Mutations in the Europe: Implications for Hereditary Breast-Ovarian Cancer Prevention and Control

EPMA Journal
BiochemistryHealth PolicyDrug Discovery
2010English

A Multi-Institutional Study of the Prevalence of BRCA1 and BRCA2 Large Genomic Rearrangements in Familial Breast Cancer Patients

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

BRCA1 and BRCA2 Mutations in Danish Families With Hereditary Breast and/or Ovarian Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2008English

Comprehensive Genetic Characterization of Hereditary Breast/Ovarian Cancer Families From Slovakia

Breast Cancer Research and Treatment
Cancer ResearchOncology
2011English

Prevalence of the BRCA1 Founder Mutation C.5266dupin Brazilian Individuals At-Risk for the Hereditary Breast and Ovarian Cancer Syndrome

Hereditary Cancer in Clinical Practice
OncologyGenetics
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy